3cxc
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | ==The structure of an enhanced oxazolidinone inhibitor bound to the 50S ribosomal subunit of H. marismortui== | |
- | + | <StructureSection load='3cxc' size='340' side='right' caption='[[3cxc]], [[Resolution|resolution]] 3.00Å' scene=''> | |
- | + | == Structural highlights == | |
- | { | + | <table><tr><td colspan='2'>[[3cxc]] is a 30 chain structure with sequence from [http://en.wikipedia.org/wiki/Haloarcula_marismortui Haloarcula marismortui]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3CXC OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3CXC FirstGlance]. <br> |
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=SLD:(3Z)-N-[(4E)-5-(4-{(5S)-5-[(ACETYLAMINO)METHYL]-2-OXO-1,3-OXAZOLIDIN-3-YL}-2-FLUOROPHENYL)PENT-4-EN-1-YL]-3-(4-METHYL-2,6-DIOXO-1,6-DIHYDROPYRIMIDIN-5(2H)-YLIDENE)PROPANAMIDE'>SLD</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3cxc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3cxc OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3cxc RCSB], [http://www.ebi.ac.uk/pdbsum/3cxc PDBsum]</span></td></tr> | ||
+ | </table> | ||
+ | == Evolutionary Conservation == | ||
+ | [[Image:Consurf_key_small.gif|200px|right]] | ||
+ | Check<jmol> | ||
+ | <jmolCheckbox> | ||
+ | <scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/cx/3cxc_consurf.spt"</scriptWhenChecked> | ||
+ | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | ||
+ | <text>to colour the structure by Evolutionary Conservation</text> | ||
+ | </jmolCheckbox> | ||
+ | </jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/chain_selection.php?pdb_ID=2ata ConSurf]. | ||
+ | <div style="clear:both"></div> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | We have developed a first generation of hybrid sparsomycin-linezolid compounds into a new family of orally bioavailable biaryloxazolidinones that have activity against both linezolid-susceptible and -resistant gram-positive bacteria as well as the fastidious gram-negative bacteria Haemophilus influenzae and Moraxella catarrahalis. The convergent synthesis of these new compounds is detailed. | ||
- | + | Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.,Zhou J, Bhattacharjee A, Chen S, Chen Y, Duffy E, Farmer J, Goldberg J, Hanselmann R, Ippolito JA, Lou R, Orbin A, Oyelere A, Salvino J, Springer D, Tran J, Wang D, Wu Y, Johnson G Bioorg Med Chem Lett. 2008 Dec 1;18(23):6175-8. Epub 2008 Oct 7. PMID:18947996<ref>PMID:18947996</ref> | |
- | + | ||
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | + | </div> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | == | + | ==See Also== |
- | + | *[[Ribosome 3D structures|Ribosome 3D structures]] | |
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
[[Category: Haloarcula marismortui]] | [[Category: Haloarcula marismortui]] | ||
- | [[Category: Duffy, E M | + | [[Category: Duffy, E M]] |
- | [[Category: Ippolito, J A | + | [[Category: Ippolito, J A]] |
- | [[Category: Kanyo, Z F | + | [[Category: Kanyo, Z F]] |
- | [[Category: Wang, D | + | [[Category: Wang, D]] |
[[Category: 50s ribosomal subunit]] | [[Category: 50s ribosomal subunit]] | ||
[[Category: Oxazolidinone]] | [[Category: Oxazolidinone]] | ||
[[Category: Ribosome]] | [[Category: Ribosome]] |
Revision as of 14:13, 17 December 2014
The structure of an enhanced oxazolidinone inhibitor bound to the 50S ribosomal subunit of H. marismortui
|